Featured Research

from universities, journals, and other organizations

Pathway May Provide Target For Treating Chronic Pain

Date:
October 19, 1999
Source:
Washington University School Of Medicine
Summary:
Researchers have found that cells in the spinal cord can transmit sensations of pain through a network of cellular receptors not previously associated with pain. This network may be responsible for transmitting chronic pain, and blocking its activity may provide a new strategy for pain management.

St. Louis, Oct. 18, 1999 -- Researchers have found that cells in the spinal cord can transmit sensations of pain through a network of cellular receptors not previously associated with pain. This network may be responsible for transmitting chronic pain, and blocking its activity may provide a new strategy for pain management.

Scientists from Washington University School of Medicine in St. Louis and Howard Hughes Medical Institute investigators at Massachusetts General Hospital and Harvard Medical School reported this finding in the November issue of Nature Neuroscience. They say serotonin--a neurotransmitter in the central nervous system (CNS)--and a cell-surface receptor called AMPA can activate silent synapses in the CNS. These synapses--junctions between nerve cells--then transmit pain signals even when no painful stimulus is present.

"Most pain medications target signals carried through a different system of receptors, so they have little or no effect on chronic pain signals transmitted at AMPA receptor sites," said Min Zhuo, Ph.D., the study's principal investigator and an assistant professor of anesthesiology and neurobiology at Washington University School of Medicine in St. Louis.

When we encounter a painful event, receptors on the skin, muscle or internal organs trigger an electrical impulse that travels along a nerve fiber to the dorsal horn of the spinal cord. That fiber connects with a nerve cell that passes the pain signal up the spinal cord to the brain. Because the signals cross junctions--synapses--on their way to the brain, they can be modified en route. For example, opioid drugs prevent signals from crossing synapses, preventing patients from feeling pain.

Silent synapses provide a second network of junctions that normally are not used, but through which pain signals can travel to the brain. Their existence was suggested more than 20 years ago but, until last year, technical limitations prevented detailed studies of how and why they become active.

In Nature last year, Zhuo and colleague Ping Li, M.D., a research associate in anesthesiology, reported that they could identify silent synapses by monitoring electrical responses of individual neurons. After these synapses were awakened, they remained active and able to relay painful sensory information to the brain even after the painful stimulus was gone.

In those experiments, the researchers showed that the silent synapses could be activated both by strong pain signals and by messages from a brain region called the rostroventral medulla (RVM), which sends chemical signals to the dorsal horn of the spinal cord. But little was known about what happens inside a nerve cell when a silent synapse is activated.

In the current study, Zhuo and colleagues found that activation of silent synapses involves an interaction between AMPA receptors and a protein called glutamate receptor interacting protein (GRIP).

"One hypothesis is that GRIP binds to the cell at an AMPA receptor site inside of the cell," Zhuo said. "Then, under certain conditions, the receptor moves itself to the synaptic part of the neuron. That movement activates the formerly silent synapse."

Receptors at synapses receive messages from other neurons. AMPA receptors are sensitive to a brain chemical called glutamate.

"AMPA receptors are highly dynamic," said co-investigator Morgan Sheng, M.D., Ph.D., associate professor of neurobiology at Massachusetts General Hospital and Harvard Medical School and assistant investigator with the Howard Hughes Medical Institute. "They can be recruited to and removed from the synapse. It's actually a marvelously simple way to regulate synaptic strength. You silence a synapse by taking away receptors and strengthen it by adding more receptors."

Zhuo compares the process to an overnight courier service. Each evening, many packages come in. But the next morning, those packages go back out, allowing the office to maintain a balance between arriving and departing packages. Too many arrivals or too few departures leads to a buildup of packages at the office and also can harm businesses that don't receive them on time.

The balance between adding and subtracting AMPA receptors appears to play a role in chronic pain. Zhuo believes most people don?t suffer from chronic pain because silent synapses remain silent under normal conditions. The GRIP protein recruits AMPA receptors and activates silent synapses only when the chemical messenger serotonin is released by nerve fibers descending from the brain.

In these experiments, Zhuo, Sheng and colleagues manufactured a protein fragment, called a peptide, to compete with GRIP at AMPA receptors in neurons. When that synthetic peptide bound to the receptors, the latter were unable to move to the synaptic site, and the silent synapse remained silent. The cells maintained their normal conversations with other neurons, however.

"That means it may be possible to prevent or reverse the activation of silent synapses without affecting other communications between neurons as a strategy for treating chronic pain," Zhuo said.

Treatment methods might include blocking serotonin on the outside of the cell or using peptides to inhibit the interaction between GRIP and AMPA inside the cell. Another strategy could involve a substance called protein kinase C (PKC). Like serotonin, large quantities of PKC can activate silent synapses. In these experiments, Zhuo and colleagues have shown that PKC activates silent synapses via the AMPA receptor, providing two potential targets for therapy.

"I think this study really supports the idea that pain can be caused by pathways that normally are not painful," Zhuo said. "The more of those targets we can identify, the greater the odds we can find medicines to help patients who are not helped by traditional drugs," Zhuo said.

###

This research was supported by grants from the National Institutes of Health.

For more information, refer to Li, Ping et. al., "AMPA receptor-PDZ interactions mediate synaptic facilitation in mammalian spinal cord," Nature Neuroscience 2(11), 972-977, Nov. 1999.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Pathway May Provide Target For Treating Chronic Pain." ScienceDaily. ScienceDaily, 19 October 1999. <www.sciencedaily.com/releases/1999/10/991019075934.htm>.
Washington University School Of Medicine. (1999, October 19). Pathway May Provide Target For Treating Chronic Pain. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/1999/10/991019075934.htm
Washington University School Of Medicine. "Pathway May Provide Target For Treating Chronic Pain." ScienceDaily. www.sciencedaily.com/releases/1999/10/991019075934.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins